FFAR2 and graft versus host disease: Because GPR43 expression on host APCs and donor conventional or regulatory T cells did not appear to be critical to reduce GVHD, we hypothesized that the expression of GPR43 in host non-hematopoietic cells, (such the GI tract where it is known to be highly expressed) is crucial for its ability to mitigate GVHD.